Legislation · British Columbia · Provincial
Bill M 249 — Pharmaceutical Risk Management and Accountability Act
Clarion tracks Bill M 249 before British Columbia — its status, sponsor, plain-language summary, and every stage it moves through, each cited to the official record and refreshed each morning.
- Status
- First Reading
- Sponsor
- Tara Armstrong
- Introduced
- 2026-05-28
- Session
- 2nd Session, 43rd Parliament
What it does
AI plain-language summary of the official text.
Bill M 249, titled the Pharmaceutical Risk Management and Accountability Act, has been introduced in the British Columbia Legislative Assembly during the 2nd Session of the 43rd Parliament. The bill is currently at First Reading, meaning it has been formally introduced but has not yet been debated or advanced through the legislative process. Based on its long title, the bill appears to address risk management and accountability measures related to pharmaceuticals, though specific provisions are not yet available at this stage.
The weekly read
Get The Dispatch in your inbox
One email a week: the bills gaining momentum, who's lobbying whom, and the passage odds that moved — across Parliament, the legislatures, and city hall. Free, in English or French.
Track Bill M 249 — and everything like it
Set a topic, and Clarion grades every new bill, debate, and lobbying filing to your files — with a calibrated passage forecast and an AI clerk that answers from the record and cites it.